REACTOME_SIGNALING_BY_PTK6 |
Return to index |
|
|
|
|
|
Order |
Gene |
Description |
ref_hepatocyte |
HepG2 |
HepG2.C3A |
HuH.7 |
SNU475 |
THLE |
liver |
1 |
UBB |
Polyubiquitin-B |
[1] |
-1.35[2] |
-1.27[3] |
-1.32[4] |
-1.69[5] |
-1.36[6] |
-0.85[7] |
2 |
RPS27A |
Ubiquitin-40S ribosomal protein S27a |
[8] |
[9] |
[10] |
[11] |
[12] |
[13] |
[14] |
3 |
UBC |
Polyubiquitin-C |
[15] |
-0.91[16] |
-0.52[17] |
-0.96[18] |
-0.84[19] |
-0.98[20] |
-0.40[21] |
4 |
RHOA |
Transforming protein RhoA |
[22] |
-0.09[23] |
-0.31[24] |
-0.29[25] |
-0.14[26] |
0.19[27] |
-0.30[28] |
5 |
SFPQ |
Splicing factor, proline- and glutamine-rich |
[29] |
0.51[30] |
0.59[31] |
0.72[32] |
0.71[33] |
0.52[34] |
-0.04[35] |
6 |
UBA52 |
Ubiquitin-60S ribosomal protein L40 |
[36] |
1.52[37] |
1.71[38] |
2.55[39] |
0.56[40] |
1.24[41] |
0.37[42] |
7 |
RAC1 |
Ras-related C3 botulinum toxin substrate 1 |
[43] |
0.45[44] |
0.40[45] |
0.91[46] |
1.10[47] |
0.96[48] |
0.06[49] |
8 |
AKT1 |
RAC-alpha serine/threonine-protein kinase |
[50] |
0.93[51] |
0.97[52] |
-0.31[53] |
1.04[54] |
0.93[55] |
0.78[56] |
9 |
STAT3 |
Signal transducer and activator of transcription 3 |
[57] |
1.40[58] |
0.18[59] |
0.71[60] |
1.33[61] |
0.48[62] |
3.43[63] |
10 |
HIF1A |
Hypoxia-inducible factor 1-alpha |
[64] |
0.69[65] |
0.64[66] |
1.24[67] |
3.37[68] |
3.63[69] |
0.22[70] |
11 |
STAP2 |
Signal-transducing adaptor protein 2 |
[71] |
-1.59[72] |
0.59[73] |
-1.53[74] |
-4.09[75] |
-2.12[76] |
-1.04[77] |
12 |
CCND1 |
G1/S-specific cyclin-D1 |
[78] |
3.90[79] |
1.67[80] |
2.30[81] |
2.97[82] |
1.36[83] |
2.08[84] |
13 |
CDK4 |
Cyclin-dependent kinase 4 |
[85] |
2.18[86] |
3.04[87] |
2.47[88] |
1.27[89] |
1.79[90] |
0.19[91] |
14 |
CRK |
Adapter molecule crk |
[92] |
0.64[93] |
0.86[94] |
0.72[95] |
0.85[96] |
1.12[97] |
1.87[98] |
15 |
PELP1 |
Proline-, glutamic acid- and leucine-rich protein 1 |
[99] |
1.16[100] |
0.65[101] |
1.42[102] |
0.94[103] |
0.45[104] |
-1.20[105] |
16 |
KHDRBS1 |
KH domain-containing, RNA-binding,
signal transduction-associated protein 1 |
1.92[106] |
1.90[107] |
2.87[108] |
2.30[109] |
1.98[110] |
0.31[111] |
17 |
NRAS |
GTPase NRas |
[112] |
1.47[113] |
2.19[114] |
2.40[115] |
2.08[116] |
1.53[117] |
0.78[118] |
18 |
CDKN1B |
Cyclin-dependent kinase inhibitor 1B |
[119] |
0.76[120] |
1.48[121] |
1.48[122] |
-0.02[123] |
0.32[124] |
0.12[125] |
19 |
EPAS1 |
Endothelial PAS domain-containing protein 1 |
[126] |
3.55[127] |
3.04[128] |
2.50[129] |
0.52[130] |
3.41[131] |
2.95[132] |
20 |
CDK2 |
Cyclin-dependent kinase 2 |
[133] |
0.43[134] |
0.88[135] |
1.05[136] |
1.07[137] |
1.53[138] |
-1.16[139] |
21 |
HRAS |
GTPase HRas |
[140] |
-0.16[141] |
-0.59[142] |
-1.58[143] |
0.14[144] |
-0.20[145] |
-1.63[146] |
22 |
SOCS3 |
Suppressor of cytokine signaling 3 |
[147] |
-3.29[148] |
-3.43[149] |
-1.91[150] |
0.29[151] |
-0.91[152] |
1.16[153] |
23 |
KHDRBS3 |
KH domain-containing, RNA-binding,
signal transduction-associated protein 3 |
-1.26[154] |
-0.71[155] |
-4.64[156] |
-5.91[157] |
-2.51[158] |
-1.54[159] |
24 |
BCAR1 |
Breast cancer anti-estrogen resistance protein 1 |
[160] |
1.98[161] |
2.13[162] |
0.81[163] |
2.46[164] |
2.06[165] |
1.09[166] |
25 |
PXN |
Paxillin |
[167] |
1.85[168] |
1.84[169] |
1.68[170] |
3.20[171] |
3.04[172] |
0.67[173] |
26 |
KRAS |
GTPase KRas |
[174] |
0.33[175] |
0.59[176] |
1.99[177] |
1.89[178] |
1.42[179] |
1.70[180] |
27 |
PTPN1 |
Tyrosine-protein phosphatase non-receptor type 1 |
[181] |
1.96[182] |
1.90[183] |
1.23[184] |
2.91[185] |
2.08[186] |
0.72[187] |
28 |
ERBB3 |
Receptor tyrosine-protein kinase erbB-3 |
[188] |
2.85[189] |
4.51[190] |
3.35[191] |
-4.78[192] |
-4.66[193] |
3.33[194] |
29 |
NR3C1 |
Glucocorticoid receptor |
[195] |
0.88[196] |
0.74[197] |
0.84[198] |
2.56[199] |
2.55[200] |
2.80[201] |
30 |
ARAP1 |
Arf-GAP with Rho-GAP domain, ANK
repeat and PH domain-containing protein 1 |
2.99[202] |
2.40[203] |
1.72[204] |
2.48[205] |
1.87[206] |
2.47[207] |
31 |
ERBB2 |
Receptor tyrosine-protein kinase erbB-2 |
[208] |
3.22[209] |
2.32[210] |
3.29[211] |
2.34[212] |
1.82[213] |
1.18[214] |
32 |
ELMO2 |
Engulfment and cell motility protein 2 |
[215] |
1.81[216] |
2.26[217] |
0.45[218] |
2.53[219] |
1.41[220] |
1.19[221] |
33 |
EGFR |
Epidermal growth factor receptor |
[222] |
0.15[223] |
0.05[224] |
2.73[225] |
1.52[226] |
2.01[227] |
3.68[228] |
34 |
ARHGAP35 |
Rho GTPase-activating protein 35 |
[229] |
3.19[230] |
3.60[231] |
3.94[232] |
3.82[233] |
3.27[234] |
4.29[235] |
35 |
CCNE1 |
G1/S-specific cyclin-E1 |
[236] |
2.08[237] |
2.47[238] |
0.46[239] |
0.68[240] |
1.15[241] |
-3.60[242] |
36 |
RASA1 |
Ras GTPase-activating protein 1 |
[243] |
1.22[244] |
2.42[245] |
2.32[246] |
3.00[247] |
1.93[248] |
2.24[249] |
37 |
DOCK1 |
Dedicator of cytokinesis protein 1 |
[250] |
2.83[251] |
3.64[252] |
3.43[253] |
-1.56[254] |
3.12[255] |
3.54[256] |
38 |
HBEGF |
Proheparin-binding EGF-like growth factor |
[257] |
-0.14[258] |
-0.67[259] |
-1.94[260] |
1.39[261] |
0.95[262] |
-1.40[263] |
39 |
GPNMB |
Transmembrane glycoprotein NMB |
[264] |
-0.03[265] |
1.26[266] |
1.44[267] |
3.50[268] |
4.26[269] |
1.15[270] |
40 |
ELMO1 |
Engulfment and cell motility protein 1 |
[271] |
-4.96[272] |
-3.00[273] |
1.00[274] |
-2.47[275] |
-5.41[276] |
3.88[277] |
41 |
NRG1 |
Pro-neuregulin-1, membrane-bound isoform |
[278] |
1.18[279] |
-4.68[280] |
-1.99[281] |
3.14[282] |
-4.46[283] |
1.80[284] |
42 |
DOK1 |
Docking protein 1 |
[285] |
-0.45[286] |
-0.58[287] |
2.43[288] |
1.34[289] |
2.62[290] |
0.75[291] |
43 |
BTC |
Probetacellulin |
[292] |
-7.30[293] |
-7.41[294] |
-3.39[295] |
-1.79[296] |
-1.94[297] |
-1.89[298] |
44 |
NRG4 |
Pro-neuregulin-4, membrane-bound isoform |
[299] |
-3.25[300] |
-0.09[301] |
-0.34[302] |
1.37[303] |
-0.95[304] |
0.09[305] |
45 |
PTK6 |
Protein-tyrosine kinase 6 |
[306] |
-0.28[307] |
2.21[308] |
0.25[309] |
-0.57[310] |
-1.12[311] |
0.45[312] |
46 |
CBL |
E3 ubiquitin-protein ligase CBL |
[313] |
5.29[314] |
4.52[315] |
4.54[316] |
6.22[317] |
5.58[318] |
4.78[319] |
47 |
LRRK2 |
Leucine-rich repeat serine/threonine-protein kinase 2 |
[320] |
[321] |
-3.72[322] |
[323] |
0.51[324] |
4.50[325] |
5.66[326] |
48 |
EREG |
Proepiregulin |
[327] |
2.60[328] |
2.80[329] |
-1.81[330] |
-0.48[331] |
4.64[332] |
-0.45[333] |
49 |
EGF |
Pro-epidermal growth factor |
[334] |
2.81[335] |
4.88[336] |
8.29[337] |
10.11[338] |
7.40[339] |
2.60[340] |
50 |
NRG2 |
Pro-neuregulin-2, membrane-bound isoform |
[341] |
[342] |
[343] |
[344] |
[345] |
[346] |
[347] |
51 |
NRG3 |
Pro-neuregulin-3, membrane-bound isoform |
[348] |
[349] |
[350] |
[351] |
[352] |
[353] |
[354] |
52 |
SRMS |
Tyrosine-protein kinase Srms |
[355] |
[356] |
[357] |
[358] |
[359] |
[360] |
[361] |
53 |
KHDRBS2 |
KH domain-containing, RNA-binding,
signal transduction-associated protein 2 |
[362] |
[363] |
[364] |
[365] |
[366] |
[367] |
54 |
ERBB4 |
Receptor tyrosine-protein kinase erbB-4 |
[368] |
[369] |
[370] |
[371] |
[372] |
[373] |
[374] |
|
|
|
|
|
|
|
|
|
|